The development and therapeutic potential of protein kinase inhibitors.
作者： Philip Cohen
DOI: 10.1016/S1367-5931(99)80067-2
关键词:
摘要: … A recurring theme throughout this review has been the potential of many protein kinase inhibitors for the treatment of more than one disease. Thus, a major reason why protein kinases …
elsevier.com
sci-hub.se 参考文章(44)
Martin Carroll, Sayuri Ohno-Jones, Shu Tamura, Elisabeth Buchdunger, Jürg Zimmermann, Nicholas B. Lydon, D. Gary Gilliland, Brian J. Druker, CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins Blood. ,vol. 90, pp. 4947- 4952 ,(1997) , 10.1182/BLOOD.V90.12.4947.4947_4947_4952
C.Q. Morris, H. Kelly, J.R. Woodburn, A. Laight, EGF receptor tyrosine kinase inhibitors as anti-cancer agents - pre-clinical and early clinical profile of ZD 1839 Cellular & Molecular Biology Letters. ,vol. 03, ,(1998)
Judith S. Sebolt-Leopold, David T. Dudley, Roman Herrera, Keri Van Becelaere, Amy Wiland, Richard C. Gowan, Haile Tecle, Stephen D. Barrett, Alexander Bridges, Sally Przybranowski, W.R. Leopold, Alan R. Saltiel, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine. ,vol. 5, pp. 810- 816 ,(1999) , 10.1038/10533
Ronald L. Magolda, Elizabeth A. Jones, James M. Trzaskos, Bruce D. Jaffee, Peggy A. Scherle, Dimuthu R. DeSilva, Margaret F. Favata, Inhibition of Mitogen-Activated Protein Kinase Kinase Blocks T Cell Proliferation But Does Not Induce or Prevent Anergy Journal of Immunology. ,vol. 160, pp. 4175- 4181 ,(1998)
Ralph Hoessel, Sophie Leclerc, Jane A. Endicott, Martin E. M. Nobel, Alison Lawrie, Paul Tunnah, Maryse Leost, Eve Damiens, Dominique Marie, Doris Marko, Ellen Niederberger, Weici Tang, Gerhard Eisenbrand, Laurent Meijer, Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases Nature Cell Biology. ,vol. 1, pp. 60- 67 ,(1999) , 10.1038/9035
Masayoshi Uehata, Toshimasa Ishizaki, Hiroyuki Satoh, Takashi Ono, Toshio Kawahara, Tamami Morishita, Hiroki Tamakawa, Keiji Yamagami, Jun Inui, Midori Maekawa, Shuh Narumiya, Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension Nature. ,vol. 389, pp. 990- 994 ,(1997) , 10.1038/40187
Vincent A. Pollack, Catherine DiOrio, April Theleman, Elsa G. Barbacci, Leslie R. Pustilnik, Mark Neveu, Mikel P. Moyer, Kenneth K. Iwata, Lee Arnold, Michael J. Morin, James D. Moyer, Bruce Boman, Penny Miller, Ann Cunningham, Margaret M. Reynolds, Don Sloan, Jonathan Doty, Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinase Cancer Research. ,vol. 57, pp. 4838- 4848 ,(1997)
D E Griswold, B Votta, J C Lee, J L Adams, A M Badger, J N Bradbeer, Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. Journal of Pharmacology and Experimental Therapeutics. ,vol. 279, pp. 1453- 1461 ,(1996)
Xiaohong Fu, Ming Cui Gong, Taiping Jia, Avril V Somlyo, Andrew P Somlyo, The effects of the Rho‐kinase inhibitor Y‐27632 on arachidonic acid‐, GTPγS‐, and phorbol ester‐induced Ca2+‐sensitization of smooth muscle FEBS Letters. ,vol. 440, pp. 183- 187 ,(1998) , 10.1016/S0014-5793(98)01455-0
Dario R Alessi, Philip Cohen, Mechanism of activation and function of protein kinase B. Current Opinion in Genetics & Development. ,vol. 8, pp. 55- 62 ,(1998) , 10.1016/S0959-437X(98)80062-2